以颈椎压迫症状为首发表现的肝细胞癌伴椎管转移1例报告

魏伏; 王健; 贺彩妮; 赵蕴玉; 李锋涛; 纪泛扑

doi:10.3969/j.issn.1001-5256.2021.01.031

以颈椎压迫症状为首发表现的肝细胞癌伴椎管转移1例报告

DOI: 10.3969/j.issn.1001-5256.2021.01.031

魏伏^{1a, 2},
王健³,
贺彩妮^1a,
赵蕴玉^1a,
李锋涛^1b,
纪泛扑^1a, ,

1a.
西安交通大学第二附属医院感染科，西安 710004
1b.
西安交通大学第二附属医院骨科，西安 710004
2.
西安市第四医院重症医学科，西安 710004
3.
空军军医大学附属唐都医院普外科，西安 710038

作者贡献声明：魏伏负责实施研究，收集、分析、解释数据, 起草文章; 王健负责实施研究，分析、解释数据; 贺彩妮负责实施研究，分析、解释数据; 赵蕴玉负责实施研究，采集数据; 李锋涛负责实施研究，外科手术，收集、分析、解释数据，指导文章撰写; 纪泛扑负责酝酿、设计、实施研究，采集数据，分析、解释数据，修改文章。

详细信息

作者简介:
魏伏(1989—)，女，主要从事重症感染方面的研究

通信作者:
纪泛扑，jifanpu1979@163.com

中图分类号: R735.7
计量
- 文章访问数: 555
- HTML全文浏览量: 157
- PDF下载量: 31
- 被引次数: 0
出版历程
- 收稿日期: 2020-06-07
- 录用日期: 2020-06-28
- 出版日期: 2021-01-20

Hepatocellular carcinoma with intraspinal metastasis initially manifesting as cervical cord compression: A case report

Fu WEI^{1a, 2},
Jian WANG³,
Caini HE^1a,
Yunyu ZHAO^1a,
Fengtao LI^1b,
Fanpu JI^{1a
, ,}

1a.
Department of Infectious Diseases, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
1b.
Department of Orthopedics, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
2.
Department of Intensive Care Unit, Xi'an No. 4 Hospital, Xi'an 710004, China
3.
Department of General Surgery, Tangdu Hospital, Air Force Medical University, Xi'an 710038, China

摘要

- 癌, 肝细胞 /
- 肿瘤转移 /
- 椎管
- Carcinoma, Hepatocellular /
- Neoplasm Metastasis /
- Spinal Canal

HTML全文

图 1 影像学检查结果

注：a，肝脏CT示肝内巨块型异常密度影，直径约135.66 mm；b，颈椎MRI示C5、C6椎体形态及信号异常，并向椎管突出。

下载: 全尺寸图片幻灯片

图 2 颈椎术后病理结果(HE染色)

注:a, ×40;b, ×100。

下载: 全尺寸图片幻灯片

参考文献(11)

[1]	WANG FS, FAN JG, ZHANG Z, et al. The global burden of liver disease: The major ipact of China[J]. Hepatology, 2014, 60(6): 2099-2108. DOI: 10.1002/hep.27406
[2]	CHEN WQ, ZHENG RS, BAADE PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338
[3]	WU W, HE X, ANDAYANI D, et al. Pattern of distant extrahepatic metastases in primary liver cancer: A SEER based study[J]. J Cancer, 2017, 8(12): 2312-2318. DOI: 10.7150/jca.19056
[4]	Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of hepatitis C (2019 version)[J]. J Clin Hepatol, 2019, 35(12): 2670-2686. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2019.12.008 中华医学会肝病学分会, 中华医学会感染病分会. 丙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2670-2686. DOI: 10.3969/j.issn.1001-5256.2019.12.008
[5]	Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2019.12.007 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007
[6]	TAMAKI K, SHIMIZU I, URATA M, et al. A patient with spinal metastasis from hepatocellular carcinoma discovered from neurological findings[J]. World J Gastroenterol, 2007, 13(19): 2758-2760. DOI: 10.3748/wjg.v13.i19.2758
[7]	OKAMOTO H, SHINKAI T, MATSUNO Y, et al. Intradural parenchymal involvement in the spinal subarachnoid space associated with primary lung cancer[J]. Cancer, 1993, 72: 2583-2588. DOI: 10.1002/1097-0142(19931101)72:9<2583::AID-CNCR2820720912>3.0.CO;2-K
[8]	BHATIA R, RAVULAPATI S, BEFELER A, et al. Hepatocellular carcinoma with bone metastases: Incidence, prognostic significance, and management—Single-Center Experience[J]. J Gastrointest Cancer, 2017, 48(4): 321-325. DOI: 10.1007/s12029-017-9998-6
[9]	CARRAT F, FONTAINE H, DORIVAL C, et al. ANRS CO22 Hepather cohort. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: A prospective cohort study[J]. Lancet, 2019, 393: 1453-1464. DOI: 10.1016/S0140-6736(18)32111-1
[10]	JI FP, ZHANG S, DENG H, et al. Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: Further evidence in decompensation cirrhosis[J]. J Hepatol, 2013, 58(6): 1262-1264. DOI: 10.1016/j.jhep.2013.01.041
[11]	JI FP, ZHOU R, WANG WJ, et al. High post-treatment α-fetoprotein levels and aspartate aminotransferase-to-platelet ratio index predict hepatocellular carcinoma in hepatitis C virus decompensated cirrhotic patients with sustained virological response after antiviral therapy[J]. J Interferon Cytokine Res, 2017, 37(8): 362-368. DOI: 10.1089/jir.2017.0040